undamentalytics Newsletter

Teladoc Health vs Veeva Systems

Veeva Systems is the larger business, with $3.20bn of revenue in fiscal 2026 against $2.53bn for Teladoc Health (1.3 times as much). Veeva Systems grew faster (16.3% against -1.5%). Veeva Systems kept more of each dollar of sales as profit: a net margin of 28.4% against -7.9%.

Latest fiscal yearTeladoc HealthTDOC, 2025Veeva SystemsVEEV, 2026
Revenue $2.53bn $3.20bn
Revenue growth -1.5% 16.3%
Net income −$200m $909m
Operating margin — 28.7%
Net margin -7.9% 28.4%
Return on equity -13.9% 13.9%
Free cash flow $285m $1.42bn
Cash $781m $1.42bn
Total debt $995m —
Debt to equity — —
Dividend per share — —
Dividend yield — —
Share buybacks — $170m
Employees 5,600 7,928
Market value $1.62bn $49.27bn
Price vs our value range Below our value range Within our value range
Moat score 36 (Weak) 79 (Strong)
Insider trades, 12 months 1 buys, 37 sales 0 buys, 16 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.